| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry.
|
Circulation
|
2010
|
2.53
|
|
2
|
Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study.
|
Pacing Clin Electrophysiol
|
1998
|
2.38
|
|
3
|
Permanent left ventricular pacing with transvenous leads inserted into the coronary veins.
|
Pacing Clin Electrophysiol
|
1998
|
2.27
|
|
4
|
Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing.
|
Am Heart J
|
1995
|
2.15
|
|
5
|
Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation.
|
Eur Heart J
|
2002
|
1.97
|
|
6
|
Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure.
|
J Am Coll Cardiol
|
1998
|
1.92
|
|
7
|
A pilot experience with permanent biventricular pacing to treat advanced heart failure.
|
Am Heart J
|
2000
|
1.78
|
|
8
|
Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia: a nine-year experience.
|
J Cardiovasc Electrophysiol
|
2000
|
1.65
|
|
9
|
Optimal right ventricular pacing site in chronically implanted patients: a prospective randomized crossover comparison of apical and outflow tract pacing.
|
J Am Coll Cardiol
|
1999
|
1.53
|
|
10
|
Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects.
|
Heart
|
2001
|
1.43
|
|
11
|
Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure.
|
Am J Cardiol
|
1999
|
1.39
|
|
12
|
Physiological relationship between AV interval and heart rate in healthy subjects: applications to dual chamber pacing.
|
Pacing Clin Electrophysiol
|
1986
|
1.28
|
|
13
|
Pacemaker lead infection: echocardiographic features, management, and outcome.
|
Heart
|
1999
|
1.28
|
|
14
|
Effects of permanent dual-chamber pacing on mitral regurgitation in hypertrophic obstructive cardiomyopathy.
|
Eur Heart J
|
1999
|
1.22
|
|
15
|
Serum alpha-L-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma?
|
Hepatology
|
1984
|
1.19
|
|
16
|
Surgery for aortic stenosis in elderly patients. A study of surgical risk and predictive factors.
|
Circulation
|
1994
|
1.10
|
|
17
|
Mahaim tachycardias.
|
Eur Heart J
|
1998
|
0.99
|
|
18
|
Peripartum cardiomyopathy in the era of cardiac magnetic resonance imaging: first results and perspectives.
|
Int J Cardiol
|
2009
|
0.96
|
|
19
|
Preliminary clinical experience with the first dual chamber pacemaker defibrillator.
|
Pacing Clin Electrophysiol
|
1997
|
0.96
|
|
20
|
Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation.
|
Am J Cardiol
|
2000
|
0.96
|
|
21
|
[Permanent atrial resynchronization by synchronous bi-atrial pacing in the preventive treatment of atrial flutter associated with high degree interatrial block].
|
Arch Mal Coeur Vaiss
|
1994
|
0.94
|
|
22
|
Patient perspective on remote monitoring of cardiovascular implantable electronic devices: rationale and design of the REMOTE-CIED study.
|
Neth Heart J
|
2014
|
0.92
|
|
23
|
Junctional rhythm during slow pathway radiofrequency ablation in patients with atrioventricular nodal reentrant tachycardia: beat-to-beat analysis and its prognostic value in relation to electrophysiologic and anatomic parameters.
|
J Cardiovasc Electrophysiol
|
2000
|
0.89
|
|
24
|
Permanent left atrial pacing with a specifically designed coronary sinus lead.
|
Pacing Clin Electrophysiol
|
1997
|
0.88
|
|
25
|
Clustering follow-up time-series recorded by cardiac implantable devices.
|
Conf Proc IEEE Eng Med Biol Soc
|
2007
|
0.88
|
|
26
|
Optimal algorithm switching for the estimation of systole period from cardiac microacceleration signals (SonR).
|
IEEE Trans Biomed Eng
|
2012
|
0.86
|
|
27
|
Failure of the exercise test to predict the anterograde refractory period of the accessory pathway in Wolff Parkinson White syndrome.
|
Pacing Clin Electrophysiol
|
1988
|
0.83
|
|
28
|
[Infections on permanent endocavitary pacemaker leads: value of transesophageal echocardiography].
|
Arch Mal Coeur Vaiss
|
1995
|
0.82
|
|
29
|
Haemodynamic benefit of a rate-adapted A-V delay in dual chamber pacing.
|
Eur Heart J
|
1989
|
0.82
|
|
30
|
Functional dissociation of cellular activation as a mechanism of Mobitz type II atrioventricular block.
|
Circulation
|
1993
|
0.80
|
|
31
|
[Importance of atrioventricular synchrony in hypertrophic obstructive cardiomyopathy treated by cardiac pacing].
|
Arch Mal Coeur Vaiss
|
1995
|
0.79
|
|
32
|
Benefits and limits of selective right ventricular cineangiography in arrhythmogenic right ventricular dysplasia.
|
Eur Heart J
|
1989
|
0.79
|
|
33
|
[AFFIRM: what we have learned ... and pending issues].
|
Ann Cardiol Angeiol (Paris)
|
2005
|
0.78
|
|
34
|
Transvenous low energy internal cardioversion for atrial fibrillation refractory to external cardioversion: do non-obese patients benefit?
|
Heart
|
2004
|
0.78
|
|
35
|
Evaluation of bepridil efficacy by electrophysiologic testing in patients with recurrent ventricular tachycardia: comparison of two regimens.
|
Cardiovasc Drugs Ther
|
1992
|
0.77
|
|
36
|
Comparative effects of ventricular resynchronization therapy in heart failure patients with or without coronary artery disease.
|
Ann Cardiol Angeiol (Paris)
|
2004
|
0.77
|
|
37
|
Can peripartum cardiomyopathy be familial?
|
Int J Cardiol
|
2008
|
0.77
|
|
38
|
Early and late cardiac ventricular reverse remodeling after catheter ablation for lone paroxysmal atrial fibrillation.
|
Ann Cardiol Angeiol (Paris)
|
2010
|
0.77
|
|
39
|
[Isolated myocardial infarction in the right ventricle: clinical and echocardiographic study].
|
Ann Cardiol Angeiol (Paris)
|
1992
|
0.75
|
|
40
|
[Is isolated atrial fibrillation genetically determined? Apropos of a familial history].
|
Arch Mal Coeur Vaiss
|
1996
|
0.75
|
|
41
|
Dietary prevention of sudden cardiac death.
|
Eur Heart J
|
2002
|
0.75
|
|
42
|
Not too late, not too fast!!
|
Eur Heart J
|
2009
|
0.75
|
|
43
|
Atrial pacing for the prevention of postoperative atrial fibrillation: how and where to pace?
|
J Am Coll Cardiol
|
2000
|
0.75
|
|
44
|
Characteristics and outcome in arrhythmogenic right ventricular dysplasia.
|
Am J Cardiol
|
1995
|
0.75
|
|
45
|
Are electronic cardiac devices still evolving?
|
Yearb Med Inform
|
2014
|
0.75
|
|
46
|
[Permanent cardiac pacing in 1993: its objectives, means and results].
|
Ann Cardiol Angeiol (Paris)
|
1994
|
0.75
|
|
47
|
[Tamponade due to Porphyromonas gingivalis].
|
Arch Mal Coeur Vaiss
|
2006
|
0.75
|
|
48
|
[Beta-blocker prescription and chronic obstructive pulmonary disease].
|
Ann Cardiol Angeiol (Paris)
|
2006
|
0.75
|
|
49
|
[Arrhythmogenic cardiomyopathies of the right ventricle].
|
Ann Cardiol Angeiol (Paris)
|
1992
|
0.75
|
|
50
|
Implantable devices to treat atrial fibrillation: real prospects or just new gimmicks?
|
Europace
|
2002
|
0.75
|
|
51
|
Coronary embolization of an intramyocardial hematoma after myocardial infarction.
|
Circulation
|
2010
|
0.75
|
|
52
|
[Medium-term results of multisite biventricular stimulation in severe cardiac failure].
|
Arch Mal Coeur Vaiss
|
2002
|
0.75
|
|
53
|
[Right ventricular infarction: recent data and future perspectives].
|
Rev Prat
|
1988
|
0.75
|
|
54
|
[Comparative study of the efficacy and tolerability of 2 modalities of intravenous cibenzoline administration in the reduction of recent spontaneous atrial arrhythmia].
|
Ann Cardiol Angeiol (Paris)
|
1995
|
0.75
|
|
55
|
The comparative antiarrhythmic and proarrhythmic activity of a 3,7-diheterobicyclo[3.3.1]nonane, BRB-I-28, and lidocaine in the 1-4-day-old infarcted dog heart.
|
Acta Physiol Hung
|
1993
|
0.75
|
|
56
|
[Efficacy and tolerance of 2 new percutaneous vena cava filters. A prospective study in 80 patients].
|
Arch Mal Coeur Vaiss
|
1992
|
0.75
|
|
57
|
[Recommendations of the French Society of Cardiology concerning the treatment of myocardial infarction after the acute phase. Epidemiology and Prevention Group].
|
Arch Mal Coeur Vaiss
|
2001
|
0.75
|
|
58
|
Facilitation of reentry by lidocaine in canine myocardial infarction.
|
Acta Physiol Hung
|
1994
|
0.75
|
|
59
|
[Factor VIII hyperactivity: an arterio-venous thrombogenic factor. Case report].
|
Arch Mal Coeur Vaiss
|
2005
|
0.75
|
|
60
|
An original defibrillation lead implantation to avoid tricuspid prosthesis damage.
|
Europace
|
2009
|
0.75
|
|
61
|
Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation.
|
Eur Heart J
|
1993
|
0.75
|
|
62
|
[Role of cardiac resynchronisation in the treatment of cardiac failure].
|
Arch Mal Coeur Vaiss
|
2004
|
0.75
|
|
63
|
[Magnetic resonance imaging in patients with pacemakers and implantable cardioverter-defibrillators: a systematic review].
|
Ann Cardiol Angeiol (Paris)
|
2009
|
0.75
|
|
64
|
Cardiac loading conditions modify the ventricular repolarization in conscious dogs with heart failure.
|
Pflugers Arch
|
2000
|
0.75
|
|
65
|
Heart rate complexity analysis in Brugada syndrome during physical stress testing.
|
Physiol Meas
|
2017
|
0.75
|
|
66
|
[New cardiac pacemakers].
|
Presse Med
|
1991
|
0.75
|
|
67
|
[Magnetocardiography: principles and potential uses in cardiology].
|
Arch Mal Coeur Vaiss
|
2002
|
0.75
|
|
68
|
Failure of epinephrine to induce severe cardiac arrhythmia in rats with ventricular hypertrophy secondary to aortic pressure overload.
|
Pharmacol Toxicol
|
1992
|
0.75
|
|
69
|
[Aneurysm of a saphenous vein aortocoronary shunt caused by fissure syndrome].
|
Ann Cardiol Angeiol (Paris)
|
1991
|
0.75
|
|
70
|
Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
|
J Cardiovasc Pharmacol
|
1996
|
0.75
|
|
71
|
[Myocardial infarction and massive biventricular thrombosis during thrombocytopenia induced by pentosan polysulfate and heparin].
|
Arch Mal Coeur Vaiss
|
1990
|
0.75
|
|
72
|
[Acute relapsing pericarditis induced by screw-in atrial pacing lead. Apropos of 3 cases].
|
Arch Mal Coeur Vaiss
|
1996
|
0.75
|
|
73
|
[Benefits and limits of single chamber atrial pacing with adaptive rate].
|
Arch Mal Coeur Vaiss
|
1990
|
0.75
|
|
74
|
[Radiofrequency ablation of atrioventricular conduction during the 5th month of pregnancy].
|
Arch Mal Coeur Vaiss
|
1992
|
0.75
|
|
75
|
[Accessory pathways of decremential conduction (Mahaim fibers). Treatment by endocavitary ablation; apropos of 8 cases].
|
Arch Mal Coeur Vaiss
|
1997
|
0.75
|
|
76
|
Facilitation of reentry by lidocaine in canine myocardial infarction.
|
Am Heart J
|
1994
|
0.75
|
|
77
|
[Wolff-Parkinson-White syndrome in a case of acute rejection of cardiac transplantation].
|
Arch Mal Coeur Vaiss
|
1990
|
0.75
|
|
78
|
[Cardiac arrest outside hospital: initial and subsequent cardiological management].
|
Arch Mal Coeur Vaiss
|
2005
|
0.75
|
|
79
|
[Implantable cardioverter defibrillators in pediatric patients: results in a series of 33 cases].
|
Arch Mal Coeur Vaiss
|
2006
|
0.75
|
|
80
|
[Value of cardiac pacing in hypertrophic obstructive cardiomyopathy refractory to medical treatment].
|
Arch Mal Coeur Vaiss
|
1995
|
0.75
|
|
81
|
[Radiofrequency catheter ablation of accessory atrioventricular pathways: initial experience in 33 patients].
|
Ann Cardiol Angeiol (Paris)
|
1993
|
0.75
|
|
82
|
[Auriculoventricular block disclosed in the exercise test].
|
Ann Cardiol Angeiol (Paris)
|
1990
|
0.75
|
|
83
|
[Value of unipolar and bipolar recordings in radiofrequency ablation of accessory atrioventricular pathways].
|
Arch Mal Coeur Vaiss
|
1996
|
0.75
|
|
84
|
[Epidemiology and comorbidities in atrial fibrillation].
|
Rev Prat
|
2013
|
0.75
|
|
85
|
Electrophysiological characterization of a novel class III antiarrhythmic agent, GLG-V-13 in the mammalian heart.
|
Acta Physiol Hung
|
1995
|
0.75
|
|
86
|
[Long QT syndrome: an underestimated cause of sudden infant death].
|
Arch Pediatr
|
2009
|
0.75
|
|
87
|
[Impact of the aetiology of cardiac failure on the correlations between electrical and mechanical asynchrony of the ventricle].
|
Arch Mal Coeur Vaiss
|
2006
|
0.75
|
|
88
|
Dynamic electrophysiology of ventriculoatrial conduction: implications for DDD and DDDR pacing.
|
Pacing Clin Electrophysiol
|
1990
|
0.75
|
|
89
|
Conversion of Mobitz type II AV block to 1:1 AV conduction by premature ventricular beats.
|
J Electrocardiol
|
1992
|
0.75
|
|
90
|
[Cough syncope caused by a possible Chlamydia pneumoniae pneumonia].
|
Rev Med Interne
|
2009
|
0.75
|
|
91
|
[Ischemic mitral regurgitation: contributions of exercise echocardiography and new therapeutic perspectives].
|
Ann Cardiol Angeiol (Paris)
|
2007
|
0.75
|
|
92
|
[Alpha-L-fucosidase. A new marker of primary liver cancer?].
|
Presse Med
|
1983
|
0.75
|
|
93
|
[Pilot study of a strategy combining coronary angioplasty with valvular and/or coronary surgery on the same day].
|
Arch Mal Coeur Vaiss
|
2006
|
0.75
|